INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Curaleaf Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, Aug. 13, 2019 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Curaleaf Holdings, Inc. (“Curaleaf” or “the Company”) (OTC: CURLF) for violations of §§10(b)… Read moreINVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Curaleaf Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Jerash Reports 23% Year-Over-Year Revenue Increase in Fiscal First Quarter 2020

Jerash Holdings (US), Inc. Companies Mentioned: Primary Exchange: NASDAQUnder the Symbol: JRSH $0.07 0.98% Tuesday, August 13, 2019 7:00 AM Commencing Initial Production Ramp at Paramount Facility NEW YORK, NY / ACCESSWIRE / August 13, 2019 / Jerash Holdings (US),… Read moreJerash Reports 23% Year-Over-Year Revenue Increase in Fiscal First Quarter 2020

Jerash Holdings to Announce Fiscal First Quarter 2020 Results on August 13

Jerash Holdings Companies Mentioned: Primary Exchange: NASDAQUnder the Symbol: JRSH $0.07 1.01% Thursday, August 8, 2019 9:30 AM ROCHESTER, NY / ACCESSWIRE / August 8, 2019 / Jerash Holdings (US), Inc. (NASDAQ:JRSH) (the “Company”) announced that it will release financial… Read moreJerash Holdings to Announce Fiscal First Quarter 2020 Results on August 13

Jerash Enters into Agreement to Acquire Land for Facility Expansion

Jerash Holdings (US), Inc. Companies Mentioned: Primary Exchange: NASDAQUnder the Symbol: JRSH ($0.1184) -1.6991 Tuesday, August 6, 2019 9:00 AM ROCHESTER, NY / ACCESSWIRE / August 6, 2019 / Jerash Holdings (US), Inc. (Nasdaq:JRSH) (the “Company”), a producer of high… Read moreJerash Enters into Agreement to Acquire Land for Facility Expansion

Global Allergy Immunotherapy Market Will Reach to USD 3.76 Billion By 2025: Zion Market Research

New York, NY, Aug. 01, 2019 (GLOBE NEWSWIRE) — Zion Market Research has published a new report titled “Allergy Immunotherapy Market by Treatment Type (SCIT and SLIT), by Allergy Type (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, and Others), and… Read moreGlobal Allergy Immunotherapy Market Will Reach to USD 3.76 Billion By 2025: Zion Market Research